PDLI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
PDL BioPharma Inc's account receivable for the three months ended in Mar. 2016 was $84.6 Mil. PDL BioPharma Inc's revenue for the three months ended in Mar. 2016 was $103.1 Mil. Hence, PDL BioPharma Inc's days sales outstanding for the three months ended in Mar. 2016 was 74.87.
During the past 13 years, PDL BioPharma Inc's highest Days Sales Outstanding was 36.10. The lowest was 0.19. And the median was 0.90.
PDL BioPharma Inc's days sales outstanding increased from Mar. 2015 (38.67) to Mar. 2016 (74.87).
Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Account receivable can be measured by Days Sales Outstanding.
PDL BioPharma Inc's Days Sales Outstanding for the fiscal year that ended in Dec. 2015 is calculated as
PDL BioPharma Inc's Days Sales Outstanding for the quarter that ended in Mar. 2016 is calculated as:
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
PDL BioPharma Inc Annual Data
PDL BioPharma Inc Quarterly Data